Pharma Manual
Pharma Manual
Pharma Manual
DEPARTMENT OF PHARMACY |
HOSPITAL POLICIES AND PROCEDURES
Staff Pharmacist
JOB DESCRIPTION:
POLICIES:
There shall be a Pharmacy and Therapeutics Committee for better patient care at a lower
cost, rational drug therapy and improved teaching on patients.
Emergency drugs and antidotes shall always be made available to hospital treatment areas
such as ER, OR, DR, RR and ICU.
The Standard Operating Procedures of the hospital shall be maintained and updated as it
serves as guide and ready reference for all the hospital pharmacy staff.
Dangerous drugs shall be issued only upon presentation of the required prescription form.
The S2 license of the prescriber must be written in the prescription.
Inventory system should be maintained adopting the First Expiry, First Out (FEFO) or
First In, First Out (FIFO) method, whichever is applicable.
There should be work flow chart post in conspicuous area within the vicinity where
pharmacy services are rendered or performed.
A written policy concerning stop orders shall be established to ensure that medication
orders are not inappropriately continued.
Expiration of drug products delivered shall be 18 months from the date of delivery and
manufacturing date shall be two (2) years from the date of delivery.
There should be a menu card displayed at the dispensing counter of the pharmacy. The
menu card should indicate all available medicines with complete specifications, dosage
forms, corresponding brand name (if any), an expiration date and cost.
Official Receipts (OR) for medicines sold shall be prepared and issued by the cash clerk
based on the charge slips issued from the pharmacy.
Records, files and reports on dangerous drugs should be maintained in compliance with
the pertinent laws, rules and regulations in RA 9165, Board Regulation No. 3 s.2003.
Medicines delivered to the hospital should be inspected and checked in the presence of a
pharmacist.
Expiration of drug products delivered shall be 18 months from the date of delivery and
manufacturing date shall be two (2) years from the date of delivery.
Proposal for the inclusion of a drug in the hospital formulary already listed in the PNDF
should be made using the Formulary Drug Request Form.
Investigational drug products must be approved by the appropriate regulatory agency for
the specific use of its principal investigator through the COH. Investigational drugs must
be evaluated and approved by the training and research department of the hospital.
Pre-signing of blank prescriptions, for any purpose is prohibited.
To make it easier for both patients and practitioners, two or more drug products are
allowed in one prescription for a particular patient.
The pharmacy shall dispense drug products and dangerous drugs in accordance with the
implementing rules and regulations of the Generic Act of 1988 (RA 6675),
Comprehensive Drug Act of 2002 (RA 9165) and other pertinent DOH policies and
regulations
Product defects or problems encountered with drug suppliers should be reported to the
hospital management through the PTC for appropriate action.
PROCEDURES:
1. Hospital Formulary System
- Process in which the list of drug products or formulary of the hospital is developed.
- It is the method where the medical staff of a hospital working with the Pharmacy and
Therapeutics Committee, evaluates, appraises, and selects from among the numerous
available medicinal agents and dosage forms those that are considered most useful in
patient care.
- The system provides the hospital pharmacists time to work with:
The medical staff in the selection, evaluation of new drug products and critical use of
therapeutic agents, and in the promotion of rational drug therapy
The nursing staff to avoid practices and procedures which may lead to medication errors
Medical and nursing staff in the implementation of policies concerning the use of drug
products in the hospital.
Objectives:
It serves to educate the physicians concerning the relative merits of the multitude of
available medicines to provide rational therapeutics and promote quality patient care.
It serves as a teaching aid to the intern and other medical staff by providing essential
information on a well-classified arrangement of therapeutically known medicines, which
have been chosen after careful consideration by the medical staff.
It prevents unnecessary duplication; wastage and confusion on prescribed medications
thus promote savings both to the hospital and to the patient.
It promotes safe, intelligent, and effective therapy in a hospital.
Title Page
Names and titles of the members of the PTC
Table of Contents
Information on hospital policies and procedures concerning drugs/medicines.
o Objectives and operation of the formulary system.
o Hospital policies governing the prescribing, dispensing, and administration of drug
products standard including drug administration times.
o Pharmacy operating procedures such as hours of service, out patient prescription
policies, pharmacy changing system, prescription labelling and packaging practices,
inpatient drug/medicine distribution procedures, the handling of drug information
requests and other services as patient education programs and pharmacy bulletin.
o Information on using the formulary, including how the formulary entries are
arranged, the information contained in each entry and the procedures for looking up a
given drug product. Reference to sources of detailed information on formulary drugs
should be included.
o Pharmacologic category of medicines.
o Brief description of the PTC, including its members, responsibilities and operation.
o Policies on pharmaceutical company representatives.
o Procedures on reporting adverse drug events and medication errors.
Drug Product List. This is the heart of the formulary. It consists of one or more
descriptive entries for each formulary item plus one or more indices to facilitate use of
the formulary.
Information to be included in each entry may vary. At a minimum, each entry must
include the following:
o Generic name of the basic drug entity or product/combination products.
o Dosage forms(s), strength(s) packaging(s) and size(s) stocked at the Pharmacy.
o Formulation (active ingredients) of a combined product.
Formulary entries maybe arrange as follows:
2. Hospital Formulary
- It is the cornerstone of drug management in the hospital, and is the principal
concern of the PTC.
- It is a continually revised compilation of pharmaceuticals, which reflects the
current clinical judgement of the medical staff and the relevant policies on
medication.
- It is tailored to fit the particular requirements of the hospital and reflects
departmental consensus on first choice treatment from the national list of
essential drugs.
Title Page
Names and titles of the members of PTC
Table of Contents
Information on hospital policies and procedures concerning drugs/medicines.
o Objectives and operation of the formulary system.
o Hospital policies governing the prescribing, dispensing, and
administration of drug products standard including drug administration
times.
o Pharmacy operating procedures such as hours of service, out-patient
prescription policies, pharmacy charging system, prescription labelling
and packaging practices, inpatient drug/medicine distribution procedures,
Regular monitoring of quality of drugs must be maintained to ensure they have not
deteriorated under storage conditions prevailing at each location.
Storing and dispensing of medicine shall maintain a record on all drugs.
Drug procurement shall maintain a systematic way.
PROCEDURES:
1. Cycle of Drug Procurement
1. Review drug selection
2. Determine quantities needed
3. Reconcile needs and funds
4. Choose procurement
5. Locate and select suppliers
6. Specify contract terms
7. Monitor order status
8. Receive and check drugs
9. Make payment
10. Distribute drugs
11. Collect consumption information
3. Methods of Procurement
The DOH hospitals shall be allowed to dispense and sell medicines under a duly
perfected Consignment Agreement.
The DOH hospitals shall be authorized to dispense consigned medicines with mark-ups
provided that the resultant retail price, i.e. with the mark-up will not result to a price
higher than the prevailing market price.
No consignment agreement shall be entered into the hospital if after computation of the
range of possible resultant mark-up prices until the level of break-even point, i.e. price
where no income will be earned by the hospital concerned would result to a price higher
than the prevailing market price.
The DOH hospitals must maintain distinct records of sales of consigned medicines,
distinctly identifying the Consignor for the purpose of tallying records and payment.
The label and packaging of the consigned goods shall be maintained as they are,
provided that the consigned goods are dispensed using their generic names only, among
the other essential requirement to be reflected in a prescription as provided by law and
pertinent statutes.
Consigned medicines sold shall be issued with separate Official Receipts to facilitate
balancing of sales records and inventory.
The foregoing procedure shall apply mutate mutandis to CHDs and other health units
provided that they are authorized to set up Trust/Revolving fund as approved by the
DBM and subject to issuance of specific guidelines.
A.O No. 34-A series of 2003, shall be applicable only for the procurement of patented and
off-patient medicines, with or without brand name, that are listed in the latest edition of
the Philippine National Drug Formulary (PNDF) or as approved by the National
Formulary Committee (NFC) and are highly sought after by the general public in the
different Department of Health Hospitals.
Order shall only be applicable for DOH Botikas with Revolving Trust Fund facilities
established for the specific purpose of selling affordable medicines to the general public.
Objectives:
Provide guidelines for the different DOH hospitals in procuring fast moving and highly
sought after essential medicines.
Eliminate wastage attributed to none or slow moving medicines which expiry dates have
lapsed.
Replicate good practices/strategies displayed by DOH units that are beneficial to the
citizenry.
Concertize the government’s commitment in bringing down the cost of quality
medicines.
7. Consignment System
Administrative Order No. 5 s. 2003 (Guidelines and Procedure for the Institutionalization
of DOH Drug Consignment System) allows DOH hospitals to enter into a drug product
consignment agreement with legitimate manufacturers or suppliers which have the
capability to meet the demands of the hospital for essential medicines in a sustainable
manner.
AO No. 145 s. 2004(Revised Policies and Guidelines for the Institutionalization and
Decentralization of the DOH Drug Consignment System) was created to decentralized
certain functions performed at the DOH central office level, and thereby empowering
DOH hospitals and Centers for Health Development (CHD).
AO 145 s. 2004, AO No. 2006-0039 dated 8 December 2006 (Amended Policies and
Guidelines for the Institutionalization and Decentralization of the DOH Drug
Consignment System) was created for the following purposes:
To provide a time-bound systems and procedures that would establish the DOH
Drug Consignment System (DOHCS).
To define the attendant roles and responsibilities of perspective consignor and
Consignee.
To provide safeguards that would ensure that the system is within the framework
of existing rules and regulations on procurement used by the Government in
general and by the DOH in particular.
To amend specific provisions of A.O. No. 145 s. 2004
The DOH hospitals shall be allowed dispense and sell medicines under a duly perfected
Consignment Agreement.
The DOH hospitals shall be authorized to dispense consigned medicines with mark-ups
provided that the resultant retail price, i.e. with the mark-up will not result to a price
higher than the prevailing market price.
No consignment agreement shall be entered into the Hospital if after computation of the
range of possible resultant mark-up prices until the level of break-even point, i.e. a price
where no income will be earned by the hospital concern would result to a price higher
than the prevailing market price.
The DOH hospitals must maintain distinct records of sales of consigned medicines,
distinctly identifying the Consignor for the purpose of tallying records and payment.
The label and packaging of the consigned goods shall be maintained as they are, provided
that the consigned goods are dispensed using their generic names only, among the other
essential requirement to be reflected in a prescription as provided by law and pertinent
statutes.
Consigned medicines sold shall be issued with separate Official Receipts to facilitate
balancing of sales records and inventory.
The foregoing procedure shall apply mutate mutandis to CHDs and other health units
provided that they are authorized to set up Trust/Revolving fund as approved by the
DBM and subject to issuance of specific guidelines.
All medications are routinely stocked and stored under appropriate conditions to meet
the requirements for stability and only authorized personnel can access
PROCEDURES:
1. In Main Pharmacy:
3. Storage of Medicines
1. The Pharmacist posts data of delivered drug products in the stock card.
2. The Pharmacist/ Administrative Aide systematically arrange the stocks
3. The Pharmacist/ Administrative Aide post details of delivered drug products in the bin
card.
4. The Pharmacist/ Administrative Aide arrange carton on pallets properly.
Ensure that the room is well ventilated and protected from outside light and heat.
Place refrigerators about 10 cm away from the wall to allow movement of warm air.
Ensure that each piece of equipment is permanently connected to the electrical supply.
Keep doors and lids firmly shut.
Clean refrigerators and defrost it regularly.
Place bottles of water for maintenance of storage temperature.
Do not keep food items in the refrigerator.
The Pharmacist shall check the available stocks of all medicines daily, weekly and
monthly.
PROCEDURES:
1. Types of Inventory
a. Physical Inventory
- The quantity of inventory is determined through actual count of items
as contrasted with accepting the values shown in records. (bin and
stock cards).
- Semi-Annual Physical Inventory of drug products and other supplies is
a Commission on Audit requirement.
- Accuracy is maintained through “cycle counting” or to continually
count available drug products.
- Drugs/medicines received on the day of the inventory or shortly
thereafter shall not be counted and clearly marked “post inventory”.
b. Perpetual Inventory
- A system where information on inventory and availability is updated
in a continuous basis.
- It may be facilitated either through a manual system of visible index
cards or by means of an electronic data system.
Medication disposal should follow federal and state laws for all prescription, controlled,
and over-the-counter medications.
PROCEDURES:
1. Waste Disposal
1. The Pharmacist segregates expired, damaged and spoiled medicines.
2. The Pharmacist accomplishes Waste Material Report.
3. The Pharmacist submits Waste Material Report to the Chief Administrative Officer or
Medical Center Chief/ Chief of Hospital.
4. The Pharmacist furnishes Waste Material Report to the Property Officer.
5. The Pharmacist returns spoiled, expired and damaged medicines to the Property and
Supply Officer.
6. The Property Officer submits request for disposal with attached appropriate documents to
the Resident Auditor.
7. The Resident Auditor inspects the items and determines the value of the items to be
disposed.
8. The Resident Auditor submits recommendation of proper disposal to the Chief of
Hospital/ Medical Center Chief
9. The Chief of Hospital forwards the documents to the Disposal Committee.
10. The Disposal Committee undertake disposal of items as recommended.
11. The Property Officer accomplishes Inventory and Inspection Report, Report of Waste
Materials or Invoice Receipt as basis for dropping items from the book of accounts.
12. The Pharmacist drops from the records quantity and value of disposed medicines
Packaging Materials
Expired/ unused/ spilt/ contaminated drugs
Sharps
Cytotoxic Wastes
Empty Vials
Medical supplies used in compounding solutions
Packaging materials such as cartons, paper drug literature, ampoule beds are disposed in
black bags.
Disposal of empty vials as covered under Bureau of Food and Drugs Bureau Circular No.
16 s. 1999
Delay-to-decay process
The pharmacist/ responsible personnel must read the prescription 3 times before
dispensing to prevent wrong medication dispensing to the clients.
The pharmacist/ responsible personnel must be aware of the violative, erroneous and
impossible prescriptions.
The pharmacist/ responsible personnel must have a knowledge background on filling a
prescription of in and out patients.
PROCEDURES:
1. Dispensing Process
Read the patient’s medical chart and prepare the medication profile. The medication
profile should contain the following:
Patient’s name
Ward and bed number
Age and sex
Date admitted
Present working impression
Weight
Physician-in-charge
Medical Social Service classification (for service patients)
Copy the doctor’s order. Write the following based on category (parenteral, oral,
treatment, stat or PRN medications):
Generic name of the drug product
Brand name (in parenthesis)
Dose and frequency
Route of administration
Read the patient’s therapeutic sheet. The patient’s therapeutic sheet contains record of the
standing medication of the patient, shows the time of administration of each drug and the
compliance of patient to the therapeutic regimen.
Copy the time of administration from the therapeutic sheet, copy the time of
administration. Use Blue/Black and red colored pen for time of administration (ex.
Blue/black pen from 7am to 6pm, red pen from 7pm to 6am) If time of administration is
not yet indicated in the therapeutic sheet, use the standard time of administration.:
OD/q24 - 8am
HS - 8pm
Q12 - 8am – 8pm
Q8 - 8am - 4pm - 12mn
Q6 - 6am - 12pm – 6pm – 12 mn
Q4 - 4am – 8am- 12nn – 4pm – 8pm – 12mn
Or ask the nurse in charge what time the drug will be administered to the patient.
Sign the medical chart. Write the following on the lower side of the last order reviewed
on the medical chart:
Noted by
Signature over printed name (or trodat)
Date of review
Read the patient’s medical chart and note for any changes in the doctor’s order.
If ordering for new drug product, the pharmacist must copy the doctor’s order, read the
patient’s therapeutic sheet and copy the time of administration.
If the order is discontinue/shift/change dose and/or frequency, pharmacist must:
o Mark the old entry (use red colored ink to draw a double bar after the last time of
administration of the drug and a single line toward the edge of the medication profile
to indicate that it was discontinued, shifted or changed).
o Copy the doctor’s current order (make a new entry of the drug product based on the
current order of the doctor. Follow the guidelines for new drug/medicine order.
Sign the medical chart. Write the following on the lower left side of the last order
reviewed on the medical chart:
o “noted by”
o Signature over printed name
o Date of review
Pharmacist receives the prescription from an “in window”, fills prescription and dispense
medicine to the patient at the “out window”
The medicines must be in good condition in the original package and should be returned
within the period specified by the hospital policy.
The manufacturer’s seal must not be torn or broken.
The label is intact and readable. The lot number and expiry date indicated on the label
must be the same as those of the stocks in the pharmacy.
Returned loose tablets/capsules and refrigerated medicines are not acceptable.
The official receipt must be presented/submitted.
Justification letter from the prescriber indicating the reason for return must be attached.
A photocopy of Death Certificate may be required as deemed necessary.
POLICIES:
The Pharmacist must obtain S-3 license secured from PDEA before selling, procuring,
acquiring, dealing in or with specified dangerous drug preparations and drug preparations
in parenteral or tablet or capsule form.
PROCEDURES:
In cases of emergency where life or health is endangered, an order for dangerous drugs
made not in the prescribed form and duly signed by the purchaser should be recognized
by the license seller and forthwith supply the dangerous drugs do ordered. The purchase
order should be signed by the City/Municipal Health Officer or attending physician or
senior medical officer or police medical officer or military doctor or any available doctor
supervising the medical team or unit rendering medical service in the area where the
emergency occurred. The seller shall notify immediately the PDEA a written statement
of circumstances leading to the purchase and how the medicine was dispensed or
administered and to whom, within 7 days after the particular emergency situation has
ended.
A certified true copy or computer printout of such record covering a period of six
months, duly signed by the pharmacist or the owner of the drug store, pharmacy
shall be forwarded to the Board through PDEA, within fifteen days following the
last day of June and December of each year, with a copy thereof furnished the city
municipal health officer concerned.
The personnel responsible for prescription must know the violative, erroneous and
impossible prescriptions.
The nurse must know that Emergency prescriptions are only done by the Physician.
The nurses must assess before prescribing medications or referring to the physician
Nurses are allowed only to prescribe medications for ROUTINE CASES and the
physician must check and affix signature before going to the pharmacy for dispensing of
the written medication.
PROCEDURES:
1. Prescribing Process
1. The Nurse gets Demographic Data gathering (Name, Address, Sex, Birthday).
2. The Nurse asks the chief complaint of the patient.
3. The Nurse assesses the patient (especially the body part where he complains of pain,
itchiness,etc.)
4. The Nurse takes vital signs of the patient.
5. The Nurse refers patient to the laboratory for different tests if needed.
6. For life threatening and priority situations, the Nurse refers patient to the physician.
7. For non-life threatening and simple cases, the nurse can prescribe but make sure to let the
physician sign the prescription.
8. The Physician prescribes medications for priority and emergency cases.
9. The Physician affix signature to the prescription.
10. The Nurse reads the prescription twice or thrice before giving it to the patient.
11. The Pharmacist is responsible for drug dispensing.
2. Information of a Prescription
Full Name
Complete address or Hospital Number
Date of prescription
Name and dosage strength of the drug
Quantity of the drug to be dispensed
DEA number and signature of the physician
Frequency and route of administration.
3. Prescription Requirements
Prescriber’s Information
o Signature
o Legibility
- The prescription must be legibly and indelibly printed and cannot be written in pencil.
o Prescriber’s address.
- The prescriber’s address must be specified and clear.
Patient’s Information
PANIQUI GENERAL HOSPITAL Page 27
HOSPITAL POLICIES AND PROCEDURES
o Patient’s Address
o Patient’s Category
- Patient eligibility must be clearly identified in accordance with the Pharmaceutical Schedule. If
the prescriber has included this information on the prescription, the pharmacist may accept these
details as correct unless the Patient provides documented evidence to the contrary.
Pharmacy Stamp
Date of Dispensing
Prescription Number
Violative Prescriptions
o Where the generic name is not written.
o Where the generic name is not legible and a brand name, which is legible is written
o Where the brand name is indicated and instructions added (such as the phrase “no
substitution”) which tend to obstruct, hinder or prevent proper generic dispensing
Erroneous Prescriptions
o Where the brand name precedes the generic name
o Where the generic name is the one in parenthesis
o Where the brand name is not in parenthesis.
o Where more than one product is prescribed on one prescription form
Impossible Prescriptions
o When only the generic name is written but is not legible
o When the generic name does not correspond to the brand name
o When both the generic name and the brand name are not legible
o When the drug product is not registered with the Bureau of Food and Drugs
Every clinical procedures of the pharmacy must be well documented from medication
intervention to patient monitoring for the adverse effects of the drug given.
Pharmacist shall prepare antidotes and emergency medicines for allergic reactions.
PROCEDURES:
1. Features of a Clinical Pharmacy Service
Physical presence of the pharmacist in the patient care area to perform to his/her
functions in close coordination with the doctor, nurse, and patient
Interpretation of the doctor’s medication orders.
Preparation of a patient drug profile
Preparation of unit doses and endorsement to the nurse.
Drug information in the patient care area (patient education and counselling)
Monitoring of Drug Therapy
Participation in the Cardio Pulmonary Resuscitation activity.
Physician
(Diagnose, Therapeutic Plans, Rational Drug Therapy)
Patient
PROCEDURES:
1. Strategies to Prevent ADR
Be updated on recent Safety Information from FDA (BFAD) regarding drugs of known
side effects. (Reports sent to FDA (BFAD) would allow the agency to pass information
on safety to other health providers and to the public).
Improve Incident Reporting System. Simplify ADR to accommodate the hectic schedule
of health personnel.
Create a better atmosphere for health care providers to report ADRs where the person
reporting error shall not fear repercussions or punishment. (Punishment is a deterrent to
reporting an error. If an error is not reported, nothing can be done to correct the situation
that created the potential for error. Health care providers find it difficult to acknowledge
mistakes).
Rely more on pharmacists to advise physicians in prescribing medications and promoting
health care provider education on medications (allows pharmacists to participate in
patient rounds with the health care team).
Improve the nursing medication and monitoring systems (changes may include bar
coding, along with the additional warnings on medications with higher potential for harm,
ex. Insulin, opiates, narcotics, potassium chloride, anti-coagulants).
Detector
Doctor, Nurse,
Pharmacist of Patient
Resident-on-Duty Nurse
Chief of Hospital
Nurses, doctors, pharmacists, or patients shall accomplish the form completely and
submits it to the ADR subcommittee.
The PTC evaluates the reports and endorses them to the Bureau of Food and Drug’s
Adverse Drug Reaction Monitoring Program/ BFAD-ADR Unit (BFAD Memorandum
Circular No. 5 s. 1994, dated April 20,1994).
Causes:
Incorrect or confusing nomenclature (abbreviations, acronyms, symbols).
Only standard nomenclature should be used.
Inappropriate dose.
Failure to specify strength.
Failure to specify exact dose.
Incorrect or unspecified route of administration or dosage form.
Inappropriate delegation of authority
Illegible written orders.
Confusing oral orders.
Failure to look at the total problem and the medication list of the patient
before prescribing.
Failure to periodically assess the need for continued therapy.
Incorrect interpretation of patient results, patient records
Incorrectly interpret or incorrectly apply a published paper or written drug
protocol
Incorrectly use, apply or calculate patient data
Make an actual error transcribing the prescription of the medication(s)
o Dispensing Errors
Causes:
Dispensing the wrong drug.
Dispensing a drug of questionable quality and/or bioavailability
Incorrect or incomplete labelling of the drug.
Incorrect number of doses.
Failure to specify or clarify drug scheduling.
Failure to set-up efficient and safe distribution system.
Failure to specify stop order times.
Failure to pick-up an error made by the prescriber and proceeds to a supply
error.
Misinterpret a correct order and proceed to make a supply error.
o Medication/Administration Errors
Causes:
Omissions. Failure to give or chart the drug, omissions for which there is no
apparent reason.
Wrong dosage. The medicine cup is the greatest source of error with liquids,
especially with smaller volumes.
Extra or unordered dose(s) given.
Unordered medication. These errors occur when there is no order for the drug
or the wrong patient receives an ordered drug.
Wrong dosage form or route of administration. Using a different form (tablet,
capsule, suspension, injection) or route (PO vs injection).
Wrong time. Variously interpreted to be 30 minutes to 2 hours before or after
the dose is ordered.
Deteriorated or outdated medication.
Fail to pick-up an error made by the prescriber and/or pharmacy and proceed
to an administration error.
Misinterpret an order and proceed to an administration error.
The Pharmacist shall monitor proper storage and handling of drug products in the IV
admixture area.
PROCEDURES:
1. Flow of Intravenous Admixture Orders
Admixture order is
sent to the Pharmacy checks the
Pharmacy prepared solution
S
Incompatibilities
checked, admixture Nurse receives
scheduled and admixture
profile reviewed
Nurse verifies
Pharmacist enters admixture against
order on patient’s physician’s order
profile
Admixture
Pharmacy prepares administered
label
Components
assembled
Unless the order specifies a particular start time or is to be initiated as a fluid change
with the next bag, all IV orders shall be entered to start “now” and should be filled and
sent to the ward as soon as possible.
All IV admixtures are checked by another pharmacist (not the pharmacist who prepared
it) before delivery.
At an appropriate time prior to the next preparation schedule, the corresponding labels
should already be prepared.
Intravenous admixtures delivered to the nursing units should be stored in the refrigerator
unless the item has a “Do Not Refrigerate” auxiliary label.
Intravenous admixtures that require protection from light shall be stored and dispensed
in brown light-resistant cover bags.
Facilities
- A centralized admixture service could be located in a reasonably small
area of the pharmacy.
- The admixture preparation area should be located in a low-traffic area
within the pharmacy.
Equipment
Typewriter
- For the preparation of a standardized admixture labels.
Computer
- Generating labels
- Maintaining a profile of current orders
- Screening for incompatibilities and duplication orders
- Generating patient charges
- Maintaining work load and product usage records
- Generating mass production or batch compounding workshops
Functions of LFH:
o Provides clean air in the working area.
o Prevents room air from entering the LFH.
o Suspends and removes contaminants introduced in the work
area by the material or personnel.
Supplies
o Needles
o Syringes
o Filter
o Administration sets
o Gauze
o Cotton
o Alcohol
o Plaster
Solution Containers
- Sterile empty evacuated containers
Protective Clothing
- Protective clothing should be considered mandatory for all health care
staff involved in the preparation of IV admixture solutions.
o Sterile gowns
o Headwear (cap) that fits snugly around the head
o Sterile gloves
o Surgical face masks
5. Labelling Requirements
The label on a parenteral solution must provide the physician or other user with
all information needed to assure the safe and proper use of the therapeutic agent.
The label should be pasted upside-down so that the information on it can easily be
read when the bottle is inverted, once placed in a hanging position.
For LVP’s and some SVP’s, the size of the label should cover a major portion of
the manufacturer’s label, leaving only the name of the original solution visible.
Label should contain the following:
Name of Patient
Ward, room and bed number
Date and time of preparation
Name of drug and contents
Dose and frequency
List of additives and their quantities (for TPN and other preparations which
contain more than one drug)
Rate of IV infusion
Expiration date (including the specific time)
Name and signature of pharmacist who prepared the solution
Countersignature of the pharmacist who checked the solution
Special precaution, storage requirement, and instruction
Types of Incompatibilities
Physical Incompatibilities
- Occur when two drugs/medicines combined in a solution produce a change
in the appearance of that solution. This visual change may be recognized as a
change in color, evolution of a gas, development of a haze, or formation of a
precipitate.
Chemical Incompatibilities
- Occur when two drugs/medicines react to cause the chemical degradation of
one or both drugs. This type of incompatibility may not be detected visually,
but its occurrence can be detected by analytical methods.
Therapeutic Incompatibilities
- Occur when two drugs/medicines are administered together to produce a
response differing in nature or intensity from that intended. Therapeutic
incompatibilities generally occur at the site of the drug action, example, at the
bacterial cell wall.
Ph OF admixture
- The most common cause of incompatibilities is a combination of two drugs
that results in a pH unsuitable for one of them.
Complexation
- A reaction between products that inactivates them, example: combination of
tetracycline with a calcium-containing drug. The chemical complex formed
between tetracycline and calcium reduces the antibacterial activity of
tetracycline.
Light
- Exposure of some drugs to light may cause destruction or reduce the potency
of the drug.
Degree of Dilution
- The concentration of the drug or its degree of dilution in solution may be a
factor in its compatibility with other drugs. Up to 15 mEq of calcium can be
added to a liter of solution containing to 30 mEq of phosphate without
precipitation occurring. Higher concentrations of either drug, however, result
in precipitation.
Time
- Most drugs/medicines degrade in a relatively short time when placed in an
IV solution. Similarly, many incompatibilities are not instantaneous, but
develop over time.
Parenteral Solution
- Some drugs/medicines have very specific directions for their preparations.
For example, amphotericin B must be reconstituted with sterile water for
injection without a bacteriostatic agent and then further diluted only with 5%
dextrose injection. Amphotericin B is not compatible with normal saline. Not
only is the solution designated as 5% dextrose injection but the PH must be
above 4.2.
Temperature
- The degradation of a drug/medicine may be regarded as a chemical reaction.
Heat increases the rate of most chemical reactions. Thus, one would expect
solutions to be more stable at refrigeration temperature than at room
temperature.
Order of mixing
- The order of adding drugs/medicines to the solution maybe a factor in
incompatibility. If two drugs are not well diluted before they come in contact
in the solution, they may react chemically. When making parenteral nutrition
solutions, incompatible electrolytes such as calcium or magnesium with
phosphate are commonly prescribed. By adding the electrolytes last and
mixing well after each condition, the electrolytes are well diluted, when they
come in contact with each other, and the chance of precipitation.
Minimizing Incompatibilities